Krensavage Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.78M | Sell |
|
|||||
|
2023
Q2 | $2.21M | Sell |
|
|||||
|
2023
Q1 | $3.23M | Sell |
|
|||||
|
2022
Q4 | $3.36M | Sell |
|
|||||
|
2022
Q3 | $3.2M | Buy |
|
|||||
|
2022
Q2 | $5.38M | Buy |
|
|||||
|
2022
Q1 | $5.68M | Buy |
|
|||||
|
2021
Q4 | $5.42M | Sell |
|
|||||
|
2021
Q3 | $6.01M | Buy |
|
|||||
|
2021
Q2 | $3.03M | Buy |
|